Who owns COEPTIS THERAPEUTICS HLDGS I?
- Ticker: COEP
- CUSIP Number: 19207a207
Tip: Access positions for across all investors
Analyze quarterly positions in Coeptis Therapeutics Hldgs I with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Coeptis Therapeutics Hldgs I stock
Who bought or sold COEPTIS THERAPEUTICS HLDGS I this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| State Street Corporation | 27k | $301k | 0% | Mar 2026 |
|
| Morgan Stanley | 201.00 | $2.3k | 0% | Mar 2026 |
|
Who sold out of Coeptis Therapeutics Hldgs I?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Vanguard Capital Management | Mar 2026 | 321k | $3.6M |
| Geode Capital Management | Mar 2026 | 53k | $596k |
| Vanguard Fiduciary Trust | Mar 2026 | 25k | $276k |
| United Capital Financial Advisers | Mar 2026 | 20k | $224k |
| BlackRock | Mar 2026 | 14k | $152k |
| Northern Trust | Mar 2026 | 12k | $137k |
| Steward Partners Investment Advisory | Mar 2026 | 5.0k | $56k |
| Vanguard Global Advisers | Mar 2026 | 1.7k | $19k |